CKD Monitoring Referral Guidance NICE — ESENeph MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — CKD G3bA2 warrants nephrology referral consideration; monitoring at least 2-3 times per year with eGFR and uACR; NICE CG182 recommends referral for accelerating decline, ACR ≥70, or complications
NICE CG182 provides specific referral and monitoring guidance based on CKD stage and risk category. CKD G3b warrants at least 2-3 eGFR and uACR measurements per year. Referral to nephrology is recommended for: eGFR <30 (G4-5), ACR ≥70 mg/mmol, accelerating eGFR decline (>5 mL/min/year or >25% decline in 12 months), uncontrolled hypertension despite ≥4 agents, suspected rare/genetic cause, or complications requiring specialist input. This patient with G3bA1 from known IgAN who is stable may be managed with shared care between nephrology and primary care.
Reference: NICE CG182 2014 (updated 2023) – CKD